DekaBank Deutsche Girozentrale’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-21,800	Closed	-$293K	–	1176
2019 Q2	$293K	Buy	21,800 +8,500	+64%	+$80.8K	﹤0.01%	974
2019 Q1	$336K	Buy	13,300 +2,400	+22%	+$19.5K	﹤0.01%	980
2018 Q4	$91K	Sell	10,900 -2,400	-18%	-$38.6K	﹤0.01%	1071
2018 Q3	$336K	Sell	13,300 -300	-2%	-$7.14K	﹤0.01%	1002
2018 Q2	$425K	Hold	13,600	–	–	﹤0.01%	939
2018 Q1	$364K	Buy	+13,600	New	+$407K	﹤0.01%	915

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DekaBank Deutsche Girozentrale's DOVA Position: Q3 2019 in Review

DekaBank Deutsche Girozentrale sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 21,800 shares — an estimated $293K sold.

DekaBank Deutsche Girozentrale first reported a position in DOVA in Q1 2018 and held it in 6 quarters. The position peaked at $425K in Q2 2018. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

DekaBank Deutsche Girozentrale reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 21,800 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $293K.
DekaBank Deutsche Girozentrale first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
DekaBank Deutsche Girozentrale's Dova Pharmaceuticals, Inc. Common Stock position peaked at $425K in Q2 2018.
72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.